Stock DNA
Pharmaceuticals & Biotechnology
CNY 2,108 Million (Mid Cap)
42.00
NA
0.49%
0.14
6.61%
1.24
Revenue and Profits:
Net Sales:
287 Million
(Quarterly Results - Sep 2025)
Net Profit:
28 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
42.94%
0%
42.94%
6 Months
48.35%
0%
48.35%
1 Year
65.12%
0%
65.12%
2 Years
208.8%
0%
208.8%
3 Years
120.64%
0%
120.64%
4 Years
109.89%
0%
109.89%
5 Years
0%
0%
0.0%
Jiangsu Hanvo Safety Product Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.67%
EBIT Growth (5y)
-4.64%
EBIT to Interest (avg)
47.82
Debt to EBITDA (avg)
0.56
Net Debt to Equity (avg)
0.19
Sales to Capital Employed (avg)
0.65
Tax Ratio
11.51%
Dividend Payout Ratio
18.73%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.18%
ROE (avg)
10.37%
Valuation key factors
Factor
Value
P/E Ratio
42
Industry P/E
Price to Book Value
3.73
EV to EBIT
52.88
EV to EBITDA
27.78
EV to Capital Employed
3.21
EV to Sales
4.34
PEG Ratio
4.32
Dividend Yield
0.19%
ROCE (Latest)
6.07%
ROE (Latest)
8.97%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
287.10
357.90
-19.78%
Operating Profit (PBDIT) excl Other Income
38.60
66.40
-41.87%
Interest
3.40
4.20
-19.05%
Exceptional Items
0.00
0.00
Consolidate Net Profit
28.00
47.10
-40.55%
Operating Profit Margin (Excl OI)
134.30%
120.60%
1.37%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is -19.78% vs 40.63% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is -40.55% vs -9.42% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,266.20
967.10
30.93%
Operating Profit (PBDIT) excl Other Income
200.70
176.40
13.78%
Interest
8.50
2.40
254.17%
Exceptional Items
0.20
0.00
Consolidate Net Profit
125.50
110.90
13.17%
Operating Profit Margin (Excl OI)
86.00%
107.10%
-2.11%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 30.93% vs 8.81% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 13.17% vs -11.84% in Dec 2023
About Jiangsu Hanvo Safety Product Co., Ltd. 
Jiangsu Hanvo Safety Product Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






